Septerna (SEPN) Current Assets (2023 - 2026)
Septerna's quarterly Current Assets came in at $368.1 million in Q1 2026, up 7.47% year-on-year from $342.5 million in Q1 2025, and down 10.44% quarter-over-quarter from $411.0 million in Q4 2025.
Septerna has reported Current Assets for 4 years, with the latest figure at $368.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 7.47% year-over-year to $368.1 million; the trailing twelve-month figure through Mar 2026 stood at $368.1 million (up 7.47% YoY), and the FY2025 full-year result was $411.0 million, up 15.17% from the prior year.
- Current Assets for Q1 2026 stood at $368.1 million, down from $411.0 million in the prior quarter.
- The five-year high for Current Assets was $491.7 million in Q3 2025, with the low at $112.7 million in Q4 2023.
- Average Current Assets over 4 years is $318.8 million, with a median of $349.6 million recorded in 2024.
- Year-over-year, Current Assets soared 268.55% in 2025 and increased 7.47% in 2026.
- Tracing SEPN's Current Assets over 4 years: stood at $112.7 million in 2023, then jumped by 216.68% to $356.8 million in 2024, then increased by 15.17% to $411.0 million in 2025, then declined by 10.44% to $368.1 million in 2026.
- The last three Current Assets figures came in at $368.1 million (Q1 2026), $411.0 million (Q4 2025), and $491.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 368.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368.06 Mn |
| Dec 31, 2025 | 410.96 Mn |
| Sep 30, 2025 | 491.68 Mn |
| Jun 30, 2025 | 334.14 Mn |
| Mar 31, 2025 | 342.47 Mn |
| Dec 31, 2024 | 356.82 Mn |
| Sep 30, 2024 | 133.41 Mn |
| Dec 31, 2023 | 112.68 Mn |